Prognostic role of the platelet to lymphocyte ratio (PLR) in the clinical outcomes of patients with advanced lung cancer receiving immunotherapy: A systematic review and meta-analysis

BackgroundIt remains controversial whether the platelet to lymphocyte ratio (PLR) serves as a potential indicator for the efficacy of immunotherapy in advanced lung cancer. This meta-analysis aimed to address this concern.MethodsUp to March 2022, we searched PubMed, Embase, Web of Science and the Co...

詳細記述

書誌詳細

出版年:	Frontiers in Oncology
主要な著者:	Ke Zhou, Jie Cao, Huahang Lin, Linchuan Liang, Zhongzhong Shen, Lei Wang, Zhiyu Peng, Jiandong Mei
フォーマット:	論文
言語:	英語
出版事項:	Frontiers Media S.A. 2022-08-01
主題:	platelet to lymphocyte ratio advanced lung cancer immune checkpoint inhibitor prognosis immunotherapy biomarker
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fonc.2022.962173/full